• Home
  • About Us
    • About Us
    • Subscribe
    • Privacy Policy
  • Advertise
    • Advertise On IP Watch
    • Editorial Calendar
  • Videos
  • Links
  • Help

Intellectual Property Watch

Original news and analysis on international IP policy

  • Copyright
  • Patents
  • Trademarks
  • Opinions
  • People News
  • Venues
    • Bilateral/Regional Negotiations
    • ITU/ICANN
    • United Nations – other
    • WHO
    • WIPO
    • WTO/TRIPS
    • Africa
    • Asia/Pacific
    • Europe
    • Latin America/Caribbean
    • North America
  • Themes
    • Access to Knowledge/ Open Innovation & Science
    • Food Security/ Agriculture/ Genetic Resources
    • Finance
    • Health & IP
    • Human Rights
    • Internet Governance/ Digital Economy/ Cyberspace
    • Lobbying
    • Technical Cooperation/ Technology Transfer
  • Health Policy Watch

Top IP-Watch Stories Of 2010: Copyright Fights, ACTA, Medicines Access

30/12/2010 by William New and Catherine Saez, Intellectual Property Watch Leave a Comment

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to email this to a friend (Opens in new window)
  • Click to print (Opens in new window)

At Intellectual Property Watch, a list of the top 25 posts of 2010 reveals your – our readers’ – top interests of the past year.

The clear winner in terms of frequency on the list was the Anti-Counterfeiting Trade Agreement (ACTA), as about a third of the top stories dealt with that treaty in the headline and several more indirectly. But the top two on the list were articles about the ongoing struggle to balance the push by copyright holders for greater protection in the digital environment with the push to ensure that knowledge may be accessed by the maximum number of people. Given that stories about enforcement far outnumber stories about new ideas to spread open access or to generate revenue, one might conclude that enforcement may be the core business model for many.

Patents also came in strong on the list, with US patent reform, technology transfer, biotechnology, compulsory licences, trade and pharmaceuticals, and the US Supreme Court’s Bilski decision all making appearances.

Among the top stories was one based on a document found on Wikileaks showing undue influence of the pharmaceutical industry in the WHO’s negotiations on financing for research and development for neglected diseases.

It also is notable that stories involving the World Trade Organization generally outdid stories about the World Intellectual Property Organization, with a few exceptions, such as the WIPO Development Agenda Group.

Several of the most-read articles were pieces in the Inside Views column, which are opinion pieces from outside contributors. Near the top was a piece on technology transfer, IP and development by Cheikh Kane, a lawyer who interned with Intellectual Property Watch. Also popular during the year but not included on the list were the dozens of news briefs in our website column called the IP Burble.

There were a few seemingly unique topics that made the list, for instance, indigenous peoples’ rights. Policymakers take note: global IP policy may be ignoring indigenous rights, but our readers made that story number 12 on the list last year!

We would like to take a moment to remind you that good reporting requires your support. Please subscribe online or contact wnew@ip-watch.ch to discuss ways to provide support to our non-profit activities.

The Top 25 IP-Watch Posts Of 2010

1. Lessig Calls For WIPO To Lead Overhaul Of Copyright System

2. Inside Views: Copyright Law Reform in Brazil: Anteprojeto or Anti-project?

3. ACTA: No More Negotiating Rounds Planned; Latest Text To Be Released

4. New Senate Patent Reform Bill Details Released

5. Europe Learns The Truth(s) About ACTA

6. Inside Views: The Relationship Between IP, Technology Transfer, and Development

7. Year Ahead: Five Key IP Cases To Watch In The United States In 2010

8. China, India To Raise Concerns At WTO About “TRIPS-Plus” Measures, ACTA

9. The Future Of Biotechnology Patents In The European Union

10. Ecuador Grants First Compulsory Licence, For HIV/AIDS Drug

11. New US IP Enforcement Plan May Have International Impact

12. UN Report: Indigenous Rights Ignored In Global IP Policy

13. Counterfeit Medicines In WTO Dispute Process, Heating Up At WHO

14. New WIPO Development Agenda Group Seeks Transformation Of UN Agency

15. Leaked ACTA Text Shows Possible Contradictions With National Laws

16. New Business Models Proposed In Debate On EU Culture And Copyright

17. Inside Views: The World Is Going Flat(Rate)

18. Efficacy Of TRIPS Public Health Amendment In Question At WTO

19. WIPO, WTO Requested To Advise On Anti-Counterfeiting Treaty

20. In Bilski Decision, US Supreme Court Adopts Tough But Vague Test for Business Method Patents

21. Confidential Documents From WHO R&D Finance Group, Industry, Raise Concern

22. FIFA, Vuvuzelas And Facebook: The Global Trophy Of IP Protection

23. ACTA Negotiators Vow To Mesh With National-Level Rights; Withhold New Text

24. WIPO Sees First Real Progress In 10 Years On Text For Protection Of Folklore

25. Submissions To US Unilateral IP Enforcement Process Highlight Piracy, Health, and ACTA

[Note: Based on Google Analytics. Results should be considered estimates and do not account for differences in the amount of time that stories were on the website from early to late in the year.]

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to email this to a friend (Opens in new window)
  • Click to print (Opens in new window)

Related

William New may be reached at wnew@ip-watch.ch.

Catherine Saez may be reached at csaez@ip-watch.ch.

Creative Commons License"Top IP-Watch Stories Of 2010: Copyright Fights, ACTA, Medicines Access" by Intellectual Property Watch is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Filed Under: Features, IP Policies, Themes, Venues, Access to Knowledge/ Education, Bilateral/Regional Negotiations, Biodiversity/Genetic Resources/Biotech, Copyright Policy, Development, Enforcement, English, Environment, Europe, Health & IP, Human Rights, IP Law, Information and Communications Technology/ Broadcasting, Innovation/ R&D, Lobbying, North America, Patents/Designs/Trade Secrets, Technical Cooperation/ Technology Transfer, Trademarks/Geographical Indications/Domains, Traditional and Indigenous Knowledge, WHO, WIPO, WTO/TRIPS

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

  • Email
  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • Vimeo
My Tweets

IPW News Briefs

Saudis Seek Alternative Energy Partners Through WIPO Green Program

Chinese IP Officials Complete Study Of UK, European IP Law

Perspectives on the US

In US, No Remedies For Growing IP Infringements

US IP Law – Big Developments On The Horizon In 2019

More perspectives on the US...

Supported Series: Civil Society And TRIPS Flexibilities

Civil Society And TRIPS Flexibilities Series – Translations Now Available

The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa

Read the TRIPS flexibilities series...

Paid Content

Interview With Peter Vanderheyden, CEO Of Article One Partners

More paid content...

IP Delegates in Geneva

  • IP Delegates in Geneva
  • Guide to Geneva-based Public Health and IP Organisations

All Story Categories

Other Languages

  • Français
  • Español
  • 中文
  • اللغة العربية

Archives

  • Archives
  • Monthly Reporter

Staff Access

  • Writers

Sign up for free news alerts

This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy

Copyright © 2022 · Global Policy Reporting

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.